TrialPanorama/TrialPanorama-database huggingface dataset:
Study 22713245 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study 22713245 — Predictive Biomarker (PRD): RXRA mRNA
Genes: RXRA; NR2B1
Study 22713245 — Predictive Biomarker (PRD): PPARGC1A mRNA
Genes: PPARGC1A; LEM6; PGC1; PGC1A; PPARGC1
Study 22713245 — Predictive Biomarker (PRD): STAT1 mRNA
Genes: STAT1
Study 22713245 — Predictive Biomarker (PRD): IRF9 mRNA
Genes: IRF9; ISGF3G
Study 15168925 — Surrogate Endpoint (SUR): Serum potassium
Study 31669050 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 31669050 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study 30883366 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 19085014 — Predictive Biomarker (PRD): EPX mRNA
Genes: EPX; EPER; EPO; EPP
Study 18181381 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 18181381 — Surrogate Endpoint (SUR): Forced vital capacity
Study 8089468 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 26025259 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study 21726992 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 21726992 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 2104988 — Predictive Biomarker (PRD): TRH mRNA
Genes: TRH
Study 335498 — Surrogate Endpoint (SUR): Blood pressure
Study 335498 — Surrogate Endpoint (SUR): Serum potassium
Study 29427176 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 17907073 — Predictive Biomarker (PRD): NMI mRNA
Genes: NMI
Study 30308388 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 30308388 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 30308388 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study 30308388 — Predictive Biomarker (PRD): Hormone receptor
Study 26853648 — Predictive Biomarker (PRD): TLR9
Genes: CD289
Study 26853648 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study 21640257 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 21640257 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 9028818 — Predictive Biomarker (PRD): EBF1 mRNA
Genes: EBF1; COE1; EBF
Study 27176869 — Safety Biomarker (SAF): Hyaluronic acid
Study 24407028 — Surrogate Endpoint (SUR): Blood pressure
Study 16113584 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 25376735 — Surrogate Endpoint (SUR): Blood pressure
Study 25376735 — Surrogate Endpoint (SUR): Bone mineral density
Study 22611047 — Surrogate Endpoint (SUR): Blood pressure
Study 30887178 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study 30887178 — Predictive Biomarker (PRD): AGER mRNA
Genes: AGER; RAGE
Study 30887178 — Predictive Biomarker (PRD): COMP mRNA
Genes: COMP
Study 30887178 — Predictive Biomarker (PRD): miR-21-5p
Genes: MIR21
Study 30887178 — Monitoring Biomarker (MOI): miR-301a-3p
Genes: MIR301A
Study 27382274 — Monitoring Biomarker (MOI): Procalcitonin
Study 23982564 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 19293690 — Surrogate Endpoint (SUR): Blood pressure
Study 21700934 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 2984913 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 26786577 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 26786577 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 26786577 — Surrogate Endpoint (SUR): Blood pressure
Study 24119443 — Predictive Biomarker (PRD): miR-106a
Genes: MIR106A
Study 17252021 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 30544795 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 30544795 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study 30544795 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 30544795 — Surrogate Endpoint (SUR): Blood pressure
Study 19010617 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 7881024 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 26391390 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study 20920040 — Surrogate Endpoint (SUR): Blood pressure
Study 20920040 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 7651642 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study 29933716 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 29933716 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 29933716 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 29933716 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 22184409 — Predictive Biomarker (PRD): EFS mRNA
Genes: EFS; CASS3
Study 17481702 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study 21621834 — Safety Biomarker (SAF): Fibroblast growth factor 1
Genes: FGF1
Study 11811505 — Predictive Biomarker (PRD): EMD mRNA
Genes: EMD; EDMD; STA
Study 27084704 — Predictive Biomarker (PRD): MRO mRNA
Genes: MRO; B29; C18orf3
Study 11587159 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 11587159 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 9843101 — Predictive Biomarker (PRD): CAP1 mRNA
Genes: CAP1; CAP
Study 21786544 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 8993240 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study 3352906 — Predictive Biomarker (PRD): OMD mRNA
Genes: OMD; SLRR2C; UNQ190/PRO216
Study 27884690 — Predictive Biomarker (PRD): CPM mRNA
Genes: CPM
Study 27884690 — Predictive Biomarker (PRD): PPT1 mRNA
Genes: PPT1; CLN1; PPT
Study 8491660 — Predictive Biomarker (PRD): REM1 mRNA
Genes: REM1; GES; REM
Study 21712288 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 25935085 — Predictive Biomarker (PRD): DEGS1 mRNA
Genes: DEGS1; DES1; MLD; MIG15
Study 19549739 — Surrogate Endpoint (SUR): Bone mineral density
Study 8139476 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 23212456 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study 16494642 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 28032481 — Surrogate Endpoint (SUR): Blood pressure
Study 26301645 — Surrogate Endpoint (SUR): Serum creatinine
Study 24623848 — Predictive Biomarker (PRD): APOA5 mRNA
Genes: APOA5; RAP3; UNQ411/PRO773
Study 24623848 — Predictive Biomarker (PRD): SCARB1 mRNA
Genes: SCARB1; CD36L1; CLA1
Study 14607958 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 10917389 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 10917389 — Surrogate Endpoint (SUR): Serum creatinine
Study 8930228 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 8930228 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 25310146 — Safety Biomarker (SAF): Interleukin 1
Study 22057730 — Predictive Biomarker (PRD): TPR mRNA
Genes: TPR
Study 22057730 — Surrogate Endpoint (SUR): Blood pressure
Study 18602083 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 16052584 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 12444542 — Surrogate Endpoint (SUR): Blood pressure
Study 28693525 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 26540987 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 26540987 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 26540987 — Surrogate Endpoint (SUR): Blood pressure
Study 19366270 — Predictive Biomarker (PRD): AGA mRNA
Genes: AGA
Study 9893184 — Safety Biomarker (SAF): Eosinophil cationic protein
Genes: RNASE3; ECP; RNS3
Study 10607234 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 10607234 — Monitoring Biomarker (MOI): HBV DNA
Study 24968577 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 24968577 — Predictive Biomarker (PRD): GSR mRNA
Genes: GSR; GLUR; GRD1
Study 24968577 — Surrogate Endpoint (SUR): Blood pressure
Study 15483780 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 7930696 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 27573562 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 27573562 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study 27573562 — Predictive Biomarker (PRD): Hormone receptor
Study 12666111 — Surrogate Endpoint (SUR): Forced vital capacity
Study 8558219 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 23031619 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 233889 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 31937325 — Predictive Biomarker (PRD): HYLS1 mRNA
Genes: HYLS1; HLS
Study 8582461 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 8582461 — Surrogate Endpoint (SUR): Blood pressure
Study 29521573 — Safety Biomarker (SAF): HLA-DRB1
Genes: HLA-DR1B
Study 23498306 — Predictive Biomarker (PRD): PRX mRNA
Genes: PRX; KIAA1620
Study 23498306 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study 16398702 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 16398702 — Predictive Biomarker (PRD): Interleukin 5
Genes: IL5
Study 14523462 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study 14523462 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study 18394022 — Pharmacodynamic Biomarker (PDY): Cholesteryl ester transfer protein
Genes: CETP
Study 18394022 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 12738757 — Surrogate Endpoint (SUR): Blood pressure
Study 26910660 — Safety Biomarker (SAF): Hyaluronic acid
Study 20181255 — Surrogate Endpoint (SUR): Blood pressure
Study 19005398 — Predictive Biomarker (PRD): SRL mRNA
Genes: SRL
Study 6220895 — Surrogate Endpoint (SUR): Blood pressure
Study 30824336 — Surrogate Endpoint (SUR): Blood pressure
Study 12427108 — Predictive Biomarker (PRD): CYP2E1 mRNA
Genes: CYP2E1; CYP2E
Study 15701892 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study 20528593 — Surrogate Endpoint (SUR): Forced vital capacity
Study 18413638 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 20622677 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 29268619 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 20308671 — Predictive Biomarker (PRD): Hormone receptor
Study 12460864 — Predictive Biomarker (PRD): UTS2R mRNA
Genes: UTS2R; GPR14
Study 7594444 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 7594444 — Surrogate Endpoint (SUR): Blood pressure
Study 23453391 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 23193213 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 22069286 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study 18308009 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 6362343 — Surrogate Endpoint (SUR): Blood pressure
Study 6362343 — Surrogate Endpoint (SUR): Serum creatinine
Study 6362343 — Surrogate Endpoint (SUR): Serum uric acid
Study 30261084 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 30261084 — Surrogate Endpoint (SUR): Blood pressure
Study 9844957 — Predictive Biomarker (PRD): CRH mRNA
Genes: CRH
Study 16408206 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study 16408206 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 11420777 — Predictive Biomarker (PRD): NXF1 mRNA
Genes: NXF1; TAP
Study 11420777 — Surrogate Endpoint (SUR): Bone mineral density
Study 8099802 — Surrogate Endpoint (SUR): Blood pressure
Study 3332556 — Surrogate Endpoint (SUR): Serum alkaline phosphatase
Study 16003290 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 12447009 — Predictive Biomarker (PRD): DHPS mRNA
Genes: DHPS; DS
Study 10359883 — Predictive Biomarker (PRD): CD46 mRNA
Genes: CD46; MCP; MIC10
Study 7738624 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 28941976 — Predictive Biomarker (PRD): NAT8 mRNA
Genes: NAT8; CML1; GLA; TSC501
Study 26721008 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 17903627 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 17903627 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 11575408 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study 23709655 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study 1386652 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 21369549 — Predictive Biomarker (PRD): CNP mRNA
Genes: CNP
Study 3169116 — Surrogate Endpoint (SUR): Blood pressure
Study 8471660 — Surrogate Endpoint (SUR): Serum calcium
Study 22071326 — Safety Biomarker (SAF): Eosinophil cationic protein
Genes: RNASE3; ECP; RNS3
Study 18789115 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 18789115 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 28356767 — Safety Biomarker (SAF): Ornithine transcarbamylase
Genes: OTC
Study 17304422 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study 17304422 — Surrogate Endpoint (SUR): Serum creatinine
Study 9880204 — Surrogate Endpoint (SUR): Blood pressure
Study 29081250 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 29081250 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 19369828 — Surrogate Endpoint (SUR): Blood pressure
Study 11529827 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 11529827 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 2897303 — Surrogate Endpoint (SUR): Blood pressure
Study 21215227 — Surrogate Endpoint (SUR): Blood pressure
Study 15807879 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 15807879 — Surrogate Endpoint (SUR): Blood pressure
Study 30928825 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 15166013 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 15166013 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 15166013 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 15166013 — Safety Biomarker (SAF): Antithrombin-III
Genes: SERPINC1; AT3; PRO0309
Study 11704449 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 27273130 — Predictive Biomarker (PRD): S100A4 mRNA
Genes: S100A4; CAPL; MTS1
Study 1771290 — Surrogate Endpoint (SUR): Blood pressure
Study 15102658 — Predictive Biomarker (PRD): VHL mRNA
Genes: VHL
Study 15102658 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 15102658 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 9699906 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 30300367 — Predictive Biomarker (PRD): TMPRSS2 mRNA
Genes: TMPRSS2; PRSS10
Study 27927221 — Surrogate Endpoint (SUR): Serum calcium
Study 18635468 — Surrogate Endpoint (SUR): Blood pressure
Study 15009069 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 15009069 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 15009069 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 21597108 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study 7833223 — Surrogate Endpoint (SUR): Blood pressure
Study 24351556 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 24351556 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study 24351556 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 11978752 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 2319784 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 18486308 — Predictive Biomarker (PRD): PDE5A mRNA
Genes: PDE5A; PDE5
Study 8485065 — Surrogate Endpoint (SUR): Blood pressure
Study 28687420 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study 31759034 — Predictive Biomarker (PRD): LAMB2 mRNA
Genes: LAMB2; LAMS
Study 8097082 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 3709638 — Surrogate Endpoint (SUR): Blood pressure
Study 31699944 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 15350182 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 8591079 — Predictive Biomarker (PRD): TBXT mRNA
Genes: TBXT; T
Study 15499696 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 15499696 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 31753736 — Predictive Biomarker (PRD): MAS1 mRNA
Genes: MAS1; MAS
Study 29668634 — Surrogate Endpoint (SUR): Blood pressure
Study 21676230 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 17008617 — Predictive Biomarker (PRD): KLHL17 mRNA
Genes: KLHL17; AF
Study 30278462 — Predictive Biomarker (PRD): DCC mRNA
Genes: DCC; IGDCC1
Study 21247820 — Predictive Biomarker (PRD); Safety Biomarker (SAF): BHMT mRNA
Genes: BHMT
Study 21247820 — Predictive Biomarker (PRD): DNMT1 mRNA
Genes: DNMT1; AIM; CXXC9; DNMT
Study 11224480 — Surrogate Endpoint (SUR): Hematologic response
Study 31804729 — Predictive Biomarker (PRD): A1CF mRNA
Genes: A1CF; ACF; ASP
Study 25834670 — Surrogate Endpoint (SUR): Blood pressure
Study 20003208 — Surrogate Endpoint (SUR): Blood pressure
Study 31125465 — Predictive Biomarker (PRD): FGR mRNA
Genes: FGR; SRC2
Study 19923089 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 19923089 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study 15610371 — Predictive Biomarker (PRD): EPX mRNA
Genes: EPX; EPER; EPO; EPP
Study 15610371 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study 8036831 — Predictive Biomarker (PRD): PYCARD mRNA
Genes: PYCARD; ASC; CARD5; TMS1
Study 21118495 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 21118495 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 17658249 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 16363240 — Predictive Biomarker (PRD): TFPI mRNA
Genes: TFPI; LACI; TFPI1
Study 16363240 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study 16363240 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 12523169 — Predictive Biomarker (PRD): EPX mRNA
Genes: EPX; EPER; EPO; EPP
Study 8077815 — Surrogate Endpoint (SUR): Blood pressure
Study 8062564 — Surrogate Endpoint (SUR): Blood pressure
Study 3248129 — Surrogate Endpoint (SUR): Blood pressure
Study 28376642 — Surrogate Endpoint (SUR): Blood pressure
Study 16836761 — Surrogate Endpoint (SUR): Blood pressure
Study 12734789 — Predictive Biomarker (PRD): NUCB2 mRNA
Genes: NUCB2; NEFA
Study 24990032 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study 18668592 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study 12897643 — Surrogate Endpoint (SUR): Blood pressure
Study 6513433 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Adrenomedullin
Genes: ADM; AM
Study 30810500 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 30810500 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 30810500 — Safety Biomarker (SAF): Interleukin 1
Study 30810500 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Intercellular adhesion molecule 1
Genes: ICAM1
Study 19258472 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 16925685 — Safety Biomarker (SAF): Eosinophil cationic protein
Genes: RNASE3; ECP; RNS3
Study 9593493 — Predictive Biomarker (PRD): SMS mRNA
Genes: SMS
Study 26027627 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 15334791 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 11953015 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 9924263 — Predictive Biomarker (PRD): RTN1 mRNA
Genes: RTN1; NSP
Study 26615342 — Surrogate Endpoint (SUR): Serum alkaline phosphatase
Study 23635945 — Surrogate Endpoint (SUR): Blood pressure
Study 15155420 — Surrogate Endpoint (SUR): Serum triglycerides
Study 11772827 — Surrogate Endpoint (SUR): Blood pressure
Study 27768546 — Surrogate Endpoint (SUR): Blood pressure
Study 23918455 — Predictive Biomarker (PRD): ABR mRNA
Genes: ABR
Study 21403524 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 15337551 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study 28701030 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 7136544 — Surrogate Endpoint (SUR): Blood pressure
Study 16364015 — Predictive Biomarker (PRD): LIF mRNA
Genes: LIF; HILDA
Study 8393676 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 8393676 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 2434792 — Surrogate Endpoint (SUR): Blood pressure
Study 26541479 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 14661012 — Surrogate Endpoint (SUR): Serum creatinine
Study 10211915 — Predictive Biomarker (PRD): GLI2 mRNA
Genes: GLI2; THP
Study 22089058 — Monitoring Biomarker (MOI): Matrix metalloproteinase 1
Genes: MMP1; CLG
Study 22089058 — Safety Biomarker (SAF): MMP-1
Genes: MMP1
Study 9512244 — Predictive Biomarker (PRD): GYPC mRNA
Genes: GYPC; GLPC; GPC
Study 3290711 — Surrogate Endpoint (SUR): Serum creatinine
Study 26437449 — Predictive Biomarker (PRD): MARS1 mRNA
Genes: MARS1; MARS
Study 23625433 — Predictive Biomarker (PRD): SLCO1B1 mRNA
Genes: SLCO1B1; LST1; OATP1B1; OATP2; OATPC; SLC21A6